Oruka Therapeutics, Inc. (ORKA)
30.90
-0.80
(-2.52%)
USD |
NASDAQ |
Dec 29, 16:00
31.42
+0.52
(+1.68%)
Pre-Market: 08:24
Oruka Therapeutics Shareholders Equity (Quarterly): 486.79M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CDT Equity, Inc. | 4.278M |
| LENZ Therapeutics, Inc. | 193.93M |
| Liminatus Pharma, Inc. | -1.646M |
| Maze Therapeutics, Inc. | 379.44M |
| MapLight Therapeutics, Inc. | 233.52M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 509.25M |
| Total Liabilities (Quarterly) | 22.46M |
| Debt to Equity Ratio | 0.0039 |
| Current Ratio | 16.94 |
| Net Debt Paydown Yield | -0.04% |